Editorial Commentary: Prophylaxis Against Deep Venous Thrombosis Should Be the Norm After Knee Arthroscopy.
Arthroscopy
; 38(12): 3192-3193, 2022 12.
Article
en En
| MEDLINE
| ID: mdl-36462784
ABSTRACT
Knee arthroscopy has low complication rates overall, and most complications are not overly disabling. Yet one of the most concerning complications is venous thromboembolism, and pulmonary embolism (PE), in particular. The combination of low rate of venous thromboembolism in knee arthroscopy but high potential cost in the event of PE makes for a challenging risk-benefit analysis in the decision for whether to use thromboprophylaxis. Research is inherently difficult due to the infrequency of deep venous thrombosis and PE, leaving orthopaedic surgeons to fill in the gaps with clinical judgement. Risk stratification based on patient risk factors (e.g., oral contraceptives, renal disease, cardiovascular disease) and specific surgical procedure (e.g., meniscectomy, anterior cruciate ligament reconstruction) are important to define the highest-risk patients that may warrant stronger anticoagulation. Yet even in low-risk patients, given the potential severity of a PE and safety of aspirin, surgeons should consider aspirin as thromboprophylaxis.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Embolia Pulmonar
/
Trombosis de la Vena
/
Tromboembolia Venosa
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Arthroscopy
Asunto de la revista:
ORTOPEDIA
Año:
2022
Tipo del documento:
Article